OSCR

A Dynamic and Complex Early Inflammatory Response in Blood and Cerebrospinal Fluid of Severe Traumatic Brain Injury Patients: A Dual Platform Analysis.

Overview

Authors: Oskar W. Persson1,2, Karsten Ruscher1,2, Erik Uvelius1,2, Niklas Marklund1,2
  1. Department of Neurosurgery, Skåne University Hospital,Lund, S-22184 Sweden
  2. Department of Clinical Sciences, Neurosurgery, Lund University,Lund, S-22184 Sweden
Institutions: Skåne University Hospital (Sweden); Lund University (Sweden)
Journal: Inflammation, volume 49, issue 1, article 156
Dates: received 22 March 2026; accepted 17 June 2026; published online 26 June 2026; in print 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1007/s10753-026-02549-9 · PMID 42360398 · PMCID PMC13309478 · OpenAlex W4416096954
Open access: hybrid, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: human (organism), traumatic brain injury (population)
Methods: Statistics, Connectivity, Physiology & signal measures
Keywords: Traumatic brain injury, Inflammation, Electrochemiluminescence, Proximity extension assay, Cytokines, Cerebrospinal fluid
MeSH: Brain Injuries, Traumatic*, Inflammation*, Inflammation Mediators*, Adult, Aged, Biomarkers, Cytokines, Female, Humans, Luminescent Measurements, Male, Middle Aged, Prospective Studies, Young Adult (* major topic)
Topic: Traumatic Brain Injury and Neurovascular Disturbances (Clinical Neurology, Medicine), according to OpenAlex
Funding: Lund University
Citations: not cited yet (Europe PMC); 40 references in the paper

Abstract

Severe traumatic brain injury (TBI) is associated with high mortality and long-term disability. Inflammation is central to TBI pathophysiology, yet early dynamics of inflammatory mediators in blood and cerebrospinal fluid (CSF) remain incompletely understood, and commonly used assay platforms have rarely been directly compared. We aimed to characterize the inflammatory response in blood and CSF during the first week after severe TBI and to assess agreement between electrochemiluminescence (ECL) and proximity extension assay (PEA). In this prospective observational study, adults with severe TBI (n = 21) were recruited. Plasma and CSF samples were collected at two time points: days 1–3 and days 4–8. Orthopedic patients with minor extremity fractures (n = 11) served as controls. Inflammatory mediator levels were quantified using ECL (11 mediators) and PEA (45 mediators). Group differences, temporal changes, and inter-platform agreement were analyzed. In plasma, 13 mediators were increased and 3 decreased, while in CSF, 19 were increased and 3 decreased during the first week post-injury. Key mediators (IL-6, IL-8, IL-10) were consistently elevated in both compartments. When comparing analytic methods, ECL and PEA showed strong cross-platform correlations for IL-8 and IL-10 in both plasma and CSF, whereas IL-13 showed weak, non-significant correlation. However, limited interchangeability between platforms and platform-related differences across compartments and time points were also observed. Severe TBI is associated with marked, temporal and compartmentalized inflammatory response during first post-injury, particularly in CSF. Comparison of ECL and PEA showed limited interchangeability, underscoring the importance of platform awareness and interpretation in TBI biomarker studies. Clinical trial number: Not applicable.

Supplementary Information: The online version contains supplementary material available at 10.1007/s10753-026-02549-9.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Data Availability

Anonymized summary data supporting the figures and tables are included in the article. The raw cytokine/chemokine concentration matrices (PEA and ECL) and analysis scripts are available from the corresponding author upon reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Publisher: n/a → Springer Science+Business Media

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 4 authors, 6 keywords, 14 MeSH terms, 1 funder, 40 references.

Cite

This paper

Persson, O. W., Ruscher, K., Uvelius, E., & Marklund, N. (2026). A Dynamic and Complex Early Inflammatory Response in Blood and Cerebrospinal Fluid of Severe Traumatic Brain Injury Patients: A Dual Platform Analysis. Inflammation, 49(1), 156. https://doi.org/10.1007/s10753-026-02549-9

BibTeX

@article{persson2026dynamic,
author = {Persson, Oskar W. and Ruscher, Karsten and Uvelius, Erik and Marklund, Niklas},
title = {{A Dynamic and Complex Early Inflammatory Response in Blood and Cerebrospinal Fluid of Severe Traumatic Brain Injury Patients: A Dual Platform Analysis}},
journal = {Inflammation},
year = {2026},
month = jun,
volume = {49},
number = {1},
pages = {156},
publisher = {Springer Science+Business Media},
issn = {0360-3997},
doi = {10.1007/s10753-026-02549-9},
url = {https://doi.org/10.1007/s10753-026-02549-9},
pmid = {42360398},
pmcid = {PMC13309478}
}

RIS

TY - JOUR
AU - Persson, Oskar W.
AU - Ruscher, Karsten
AU - Uvelius, Erik
AU - Marklund, Niklas
TI - A Dynamic and Complex Early Inflammatory Response in Blood and Cerebrospinal Fluid of Severe Traumatic Brain Injury Patients: A Dual Platform Analysis
T2 - Inflammation
J2 - Inflammation
PY - 2026
DA - 2026/06/26
VL - 49
IS - 1
SP - 156
SN - 0360-3997
PB - Springer Science+Business Media
DO - 10.1007/s10753-026-02549-9
UR - https://doi.org/10.1007/s10753-026-02549-9
LA - en
ER -

CSL-JSON

{
"id": "10.1007/s10753-026-02549-9",
"type": "article-journal",
"title": "A Dynamic and Complex Early Inflammatory Response in Blood and Cerebrospinal Fluid of Severe Traumatic Brain Injury Patients: A Dual Platform Analysis",
"container-title": "Inflammation",
"author": [
{
"family": "Persson",
"given": "Oskar W."
},
{
"family": "Ruscher",
"given": "Karsten"
},
{
"family": "Uvelius",
"given": "Erik"
},
{
"family": "Marklund",
"given": "Niklas"
}
],
"container-title-short": "Inflammation",
"volume": "49",
"issue": "1",
"page": "156",
"DOI": "10.1007/s10753-026-02549-9",
"PMID": "42360398",
"PMCID": "PMC13309478",
"ISSN": "0360-3997",
"publisher": "Springer Science+Business Media",
"URL": "https://doi.org/10.1007/s10753-026-02549-9",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
26
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1093/braincomms/fcaf096 [code]
Influence of apolipoprotein E genotype on the proteomic profile in cerebral microdialysis after human severe traumatic brain injury: a prospective observational study.
Journal: Brain communications
In common: traumatic brain injury, 5 references
[2] doi:10.3390/ijms25094837
Early Blood-Brain Barrier Impairment as a Pathological Hallmark in a Novel Model of Closed-Head Concussive Brain Injury (CBI) in Mice.
Journal: International journal of molecular sciences
In common: traumatic brain injury, 2 references, author Niklas Marklund
[3] doi:10.1186/s12974-022-02654-0
Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury.
Journal: Journal of neuroinflammation
In common: traumatic brain injury, 4 references
[4] doi:10.1016/j.neurot.2024.e00472
Post-injury treatment with 7,8-dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injury.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
In common: traumatic brain injury, 1 reference, author Niklas Marklund
[5] doi:10.1007/s00701-024-06269-7
Contusion expansion, low platelet count and bifrontal contusions are associated with worse patient outcome following traumatic brain injury-a retrospective single-center study.
Journal: Acta neurochirurgica
In common: traumatic brain injury, author Niklas Marklund
[6] doi:10.1038/s41593-025-01877-7
Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury, enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent T<sub>reg</sub>-microglia crosstalk.
Journal: Nature neuroscience
In common: traumatic brain injury, 3 references
[7] doi:10.1186/s12950-025-00471-9
Immunological response and tissue loss in a rodent model of chronic traumatic brain injury treated with resolvin.
Journal: Journal of inflammation (London, England)
In common: traumatic brain injury, 3 references
[8] doi:10.1093/brain/awad132 [code]
Bumetanide induces post-traumatic microglia-interneuron contact to promote neurogenesis and recovery.
Journal: Brain : a journal of neurology
In common: traumatic brain injury, 3 references
[9] doi:10.1089/neur.2022.0029
Blood-Based Biomarkers of Repetitive, Subconcussive Blast Overpressure Exposure in the Training Environment: A Pilot Study.
Journal: Neurotrauma reports
In common: 3 references
[10] doi:10.1089/neu.2023.0099
Widespread White Matter Abnormalities in Concussed Athletes Detected by 7T Diffusion Magnetic Resonance Imaging.
Journal: Journal of neurotrauma
In common: traumatic brain injury, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.